ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 155594 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 155594; 2) Community: the network communities that were significantly associated with the response to NSC 155594; 3) Molecule: the relationships between components within communities and NSC 155594; 4) MDR: the compounds that were significantly associated with the NSC 155594.

NSC Compound Enrichment Correlation
NSC 724784 (1S,4R,5R,8R,12R,13S)-1,5-dimethyl-9-methylene-11,14,15,16-t etraoxatetracyclo[10.3.1.04,13.08,13]hexadec-10-yl]oxy}-3-he xenyl)oxy]-1,5,-dimethyl-9-methylene-11,14,15,16-tetraoxatet racyclo[10.3.1.0 0.00385572727186 0.39692558
NSC 740252 Null 0.00385572727186 0.2878454
NSC 750970 3-[(E)-1-(3-1-[(4-fluorophenyl)sulfonyl]-4-piperidylimidazo[1,5-a]pyridin-1-yl)methylidene]-2-indolinone 0.00385572727186 -0.24978412
NSC 627506 Null 0.00396220821750022 0.30938349
NSC 637126 Null 0.00396220821750022 0.37957765
NSC 638038 Null 0.00396220821750022 0.37007502
NSC 639518 Cyclopentanone, 2-[[4-(benzoyloxy)-3-methoxyphenyl] methylene]-5-[(dimethylamino)methyl]-, hydrochloride 0.00396220821750022 0.51396146
NSC 645389 Null 0.00396220821750022 0.6022545
NSC 667874 Null 0.00396220821750022 0.2815502
NSC 668335 Null 0.00396220821750022 0.37099531
Total:136  Current:24    [First] [Prev] [Next] [Last]